Výsledky vyhledávání - "Rosalía Vigueras-Moreno"

Akademický článek

Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico

Publikováno v: npj Vaccines, Vol 8, Iss 1, Pp 1-14 (2023)

Abstract There is still a need for safe, efficient, and low-cost coronavirus disease 2019 (COVID-19) vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we evaluated a vaccine candidate based on a

Externí odkaz: https://doaj.org/article/d2ac0c69327549fb9217708e2039498c

Zobrazit plný text záznamu

Akademický článek

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Autor: Jesús Horacio Lara-Puente, Juan Manuel Carreño, Weina Sun, Alejandro Suárez-Martínez, Luis Ramírez-Martínez, Francisco Quezada-Monroy, Georgina Paz-De la Rosa, Rosalía Vigueras-Moreno, Gagandeep Singh, Oscar Rojas-Martínez, Héctor Elías Chagoya-Cortés, David Sarfati-Mizrahi, Ernesto Soto-Priante, Constantino López-Macías, Florian Krammer, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Bernardo Lozano-Dubernard

Publikováno v: mBio, Vol 12, Iss 5 (2021)

Several highly efficacious vaccines for SARS-CoV-2 have been developed and are used in the population. However, the current production capacity cannot meet the global demand. Therefore, additional vaccines—especially ones that can be produced local

Externí odkaz: https://doaj.org/article/d47ce303ae344529b5dda46a5d3fc757

Zobrazit plný text záznamu

Safety and immunogenicity of a live recombinant Newcastle disease virus-based COVID-19 vaccine (Patria) administered via the intramuscular or intranasal route: Interim results of a non-randomized open label phase I trial in Mexico

Publikováno v: medRxiv

There is still a need for safe, efficient and low-cost coronavirus disease 2019 (COVID-19) vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we evaluated a vaccine candidate based on a live reco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3bde479e654e6ef0648aed025d62266a
https://pubmed.ncbi.nlm.nih.gov/35169806

Zobrazit plný text záznamu

Safety and Immunogenicity of a Newcastle Disease Virus Vector-Based SARS-CoV-2 Vaccine Candidate, AVX/COVID-12-HEXAPRO (Patria), in Pigs

Autor: David Sarfati-Mizrahi, Bernardo Lozano-Dubernard, Héctor Elías Chagoya-Cortés, Rosalía Vigueras-Moreno, Peter Palese, Florian Krammer, Constantino López-Macías, Oscar Rojas-Martínez, Francisco Quezada-Monroy, Felipa Castro-Peralta, Juan Manuel Carreño, Ernesto Soto-Priante, Adolfo García-Sastre, Weina Sun, Alejandro Suárez-Martínez, Gagandeep Singh, Luis Ramírez-Martínez, Georgina Paz-De la Rosa, Jesus Horacio Lara-Puente

Publikováno v: mBio, Vol 12, Iss 5 (2021)
mBio

Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) were developed in record time and show excellent efficacy and effectiveness against coronavirus disease 2019 (COVID-19). However, currently approved vaccines cannot meet th

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dc345961fcf6785368dd7a1928cfd35e
https://journals.asm.org/doi/10.1128/mBio.01908-21

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání